Identification of Retevmo:
No description |
Search images on Google Product Monograph
Active Ingredients:
- selpercatinib, 80 MG
DIN: 02516926
Dosage Form(s): CAPSULE
Route(s) of Administration: ORAL
Schedule: Prescription
Company: LOXO ONCOLOGY INC
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01E - (ATC, WHO)
- L01EX - (ATC, WHO)
- L01EX22 - SELPERCATINIB (WHO)